Cytoplasmic inclusion bodies are concentrated deposits of proteins, nucleic acids, or other molecules that accumulate inside the main compartment of a cell, outside the nucleus. Some are perfectly normal parts of cellular housekeeping, while others are hallmarks of serious diseases ranging from Parkinson’s to rabies. What makes them fascinating, and sometimes confusing, is that the same basic physical process can produce both a harmless, temporary storage depot and a pathological aggregate that kills neurons. The distinction between helpful and harmful often comes down to what the inclusion is made of, how long it persists, and whether the cell can get rid of it.
Normal Inclusion Bodies That Cells Build on Purpose
Not every inclusion body signals trouble. Healthy cells routinely assemble and disassemble two well-studied types of cytoplasmic granules: stress granules and processing bodies, commonly called P-bodies. Stress granules form when a cell encounters heat shock, oxidative damage, or viral infection. Under those conditions, the cell halts most protein production, and the stalled messenger RNA molecules cluster together with proteins into visible clumps. P-bodies, by contrast, are more closely tied to RNA degradation and silencing and can be present even in unstressed cells.
Despite overlapping in some of their protein and RNA components, stress granules and P-bodies maintain distinct spatial organizations and different functional identities. Stress granules harbor stalled translation machinery, while P-bodies concentrate the enzymes that break down or silence RNA.1PubMed Central. Relationship of GW/P-bodies with stress granules Under certain stress conditions, P-bodies physically dock with stress granules, and overexpressing certain shared proteins can even cause the two structures to fuse. Proteomic and transcriptomic profiling of these granules in human T cells has shown that despite molecular overlap, they keep distinct abilities to interact with messenger RNAs.2Cell Reports. The proteome and transcriptome of stress granules and P bodies during human T lymphocyte activation Both types of granule are temporary. Once the stress resolves, the cell disassembles them and resumes normal operations.
The proteins enriched in stress granules and P-bodies tend to share a structural trait: large stretches of intrinsically disordered regions, meaning parts of the protein that do not fold into a fixed shape. These flexible regions are especially prone to a physical process called liquid-liquid phase separation, where proteins and RNA spontaneously condense out of the surrounding cytoplasm the way oil droplets form in water.3Molecular Cell. Cytoplasmic Inclusion Bodies: Types, Formation, and Disease This mechanism turns out to be central to how many different types of inclusion bodies come into being, whether healthy or pathological.
How Inclusion Bodies Form
Two broad pathways generate most cytoplasmic inclusions. The first is phase separation, where proteins and RNA coalesce into droplet-like condensates without the help of a surrounding membrane. The second involves active transport of misfolded proteins along the cell’s internal scaffold to a central collection point.
Phase separation can be remarkably fast. Work on respiratory syncytial virus (RSV) showed that viral inclusion bodies in infected cells behave as liquid organelles: they lack membranes, they merge and deform like droplets, and fluorescent molecules within them recover their signal rapidly after being bleached, all hallmarks of a liquid phase rather than a rigid solid. These RSV inclusion bodies form through interactions between just two viral proteins, demonstrating that phase separation can be triggered by a minimal set of components.4PubMed Central. Minimal Elements Required for the Formation of Respiratory Syncytial Virus Cytoplasmic Inclusion Bodies In Vivo and In Vitro
The second pathway, aggresome formation, is more mechanical. When misfolded proteins accumulate faster than the cell’s quality-control systems can handle them, small aggregates called pre-aggresome particles nucleate in the outer cytoplasm. These particles are then loaded onto motor proteins that walk along microtubules, the cell’s internal highway, toward the microtubule-organizing center near the nucleus.5PubMed Central. Episodic transport of protein aggregates achieves a positive size selectivity in aggresome formation The motor responsible is dynein, the same molecular machine that hauls cargo throughout the cell. Research on the misfolded version of the CFTR protein (the protein defective in cystic fibrosis) confirmed that dynein and its partner dynactin physically associate with misfolded protein and drive it into aggresomes.6PubMed. Cytoplasmic dynein/dynactin mediates the assembly of aggresomes
High-resolution tracking of individual aggregates has revealed that this transport is not smooth. It happens in bursts, with longer pauses between episodes for larger particles. Intriguingly, bigger aggregates actually move faster on average, creating a kind of size-selective filter: the cell preferentially shuttles larger, potentially more dangerous clumps to the central disposal site.5PubMed Central. Episodic transport of protein aggregates achieves a positive size selectivity in aggresome formation
Inclusion Bodies in Neurodegenerative Disease
The inclusion bodies that attract the most medical attention are those found in the brains of people with neurodegenerative diseases. Each major condition has its own signature inclusion, built from a different protein gone wrong.
In Parkinson’s disease and dementia with Lewy bodies, the culprit is alpha-synuclein. This small protein normally exists in an unfolded state in the cytoplasm, but it can shift into a shape that encourages it to stick to copies of itself, forming first small clusters and eventually dense fibrillar deposits known as Lewy bodies.7PubMed Central. Alpha-synuclein biology in Lewy body diseases Chemical modifications such as phosphorylation and ubiquitination accelerate this aggregation. Studies of purified Lewy bodies from postmortem brains have confirmed that they contain both full-length and truncated, insoluble forms of alpha-synuclein.8PubMed Central. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies
Lewy body formation is not just a matter of alpha-synuclein fibers piling up. The process involves a complex interplay between fibrillization, post-translational modifications, and the trapping of cellular organelles, including mitochondria and components of the autophagy and lysosomal systems, within the growing inclusion. This entrapment disrupts mitochondrial function and synapse signaling, and evidence now suggests that the process of forming the Lewy body, rather than the mere presence of alpha-synuclein fibrils, is a major driver of neuronal death.9PubMed Central. The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration
In amyotrophic lateral sclerosis (ALS) and frontotemporal dementia, two RNA-binding proteins called TDP-43 and FUS are depleted from the nucleus and accumulate in cytoplasmic inclusions.10PubMed. Cytoplasmic functions of TDP-43 and FUS and their role in ALS Because these proteins normally regulate gene expression in the nucleus, their mislocalization creates a double problem: loss of function in the nucleus and gain of toxic function in the cytoplasm.
Huntington’s disease follows a different route. An expanded repeat of the amino acid glutamine in the huntingtin protein makes it inherently prone to misfold and aggregate.11PubMed Central. Protein aggregates in Huntington’s disease The resulting polyglutamine inclusions can form in both the cytoplasm and the nucleus, and their internal architecture has been visualized at near-atomic resolution using cryo-electron tomography, revealing networks of amyloid-like fibrils roughly 7 to 8 nanometers in diameter.12Cell. In Situ Architecture and Cellular Interactions of Polyglutamine Inclusion Bodies
Are Inclusion Bodies the Cause of Damage, or a Defense Against It?
One of the most debated questions in the field is whether the visible inclusion bodies themselves are what kills cells or whether they are actually a protective response. A growing body of evidence points toward the latter, at least in part. Smaller, soluble clusters of misfolded protein, called oligomers, appear to be far more toxic than the large, organized inclusions that eventually form.
In polyglutamine diseases, direct comparison of cell survival showed that cells containing soluble oligomers died faster than cells containing fully formed inclusion bodies or cells that held only monomers. The oligomers assembled in a length-dependent manner, with longer glutamine repeats producing more of them, and the transition from oligomer to inclusion body actually coincided with improved short-term survival.13Human Molecular Genetics. Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic The interpretation is that by sweeping toxic oligomers into a large, relatively inert deposit, the cell buys itself time.
This pattern is not unique to polyglutamine diseases. For misfolded proteins generally, accumulation into amyloid inclusions and plaques can serve a protective function by sequestering dangerous species away from the rest of the cell.14PubMed Central. Amyloid deposits: protection against toxic protein species? However, this protection has limits. When the volume of misfolded protein exceeds the cell’s capacity to safely deposit it, the system breaks down and toxic intermediates spill over. Across neurodegenerative conditions more broadly, oligomers are now considered the most toxic species of misfolded proteins, more so than the classic inclusion bodies seen in Parkinson’s or other diseases.15Brain. Oligomers: a hot topic for neurodegeneration and a note of caution for experimental models
The protective-versus-harmful debate matters for drug development. If inclusion bodies are the cell’s last-ditch containment strategy, treatments that simply break them apart without also removing the freed oligomers could actually make things worse.
Viral Inclusion Bodies as Replication Factories
Viruses have their own reasons for building cytoplasmic inclusions. Rather than representing protein gone wrong, viral inclusion bodies are purpose-built factories where the virus copies its genetic material and assembles new components.
The best-known example is the Negri body, first described in rabies-infected neurons over a century ago and still used as a diagnostic marker. Negri bodies are cytoplasmic inclusion bodies in which all the virus’s RNA species, genomic, antigenomic, and every messenger RNA, are produced.16PubMed. Structure and Function of Negri Bodies Short-pulse labeling experiments confirmed that active transcription and replication happen inside these structures, not somewhere else in the cytoplasm.17PubMed Central. Functional characterization of Negri bodies (NBs) in rabies virus-infected cells: Evidence that NBs are sites of viral transcription and replication Like the RSV inclusion bodies described earlier, Negri bodies form through phase separation, creating a concentrated reaction chamber within the cell without bothering to enclose it in a membrane.
Many other viruses use the same strategy, including Ebola, measles, and influenza. The inclusions concentrate viral components in one place, boosting the efficiency of replication and shielding viral RNA from the cell’s immune sensors. Understanding how these viral factories self-assemble has become a target for antiviral research: if you can prevent phase separation, you might block replication at its source.
Mallory-Denk Bodies and Liver Disease
Inclusion bodies are not limited to neurons and virus-infected cells. The liver produces its own distinctive type under chronic stress. Mallory-Denk bodies are irregularly shaped cytoplasmic clumps found in hepatocytes, the liver’s main functional cells, in conditions such as alcoholic hepatitis, non-alcoholic steatohepatitis, and certain drug toxicities.
Their core components are keratins 8 and 18, the intermediate filament proteins that give hepatocytes structural rigidity, along with ubiquitin and the adaptor protein p62.18PubMed. From Mallory to Mallory-Denk bodies: what, how and why? The mechanism involves chronic stress pushing protein misfolding beyond what the proteasome can handle, combined with a specific imbalance: keratin 8 levels rise above keratin 18 levels, and the excess keratin 8 gets cross-linked by the enzyme transglutaminase, creating insoluble tangles.19PubMed. Mallory-Denk-bodies: lessons from keratin-containing hepatic inclusion bodies Pathologists look for Mallory-Denk bodies on liver biopsies as a marker of ongoing hepatocyte injury, though their presence alone does not pinpoint a single cause.
How Cells Try to Clear Inclusion Bodies
Cells are not passive bystanders when inclusions form. They deploy two major cleanup systems: the proteasome, which degrades individual misfolded proteins one at a time, and autophagy, which engulfs larger aggregates whole and delivers them to lysosomes for breakdown. For neurodegenerative aggregates, specialized machinery including the disaggregase VCP/p97 and the HSP70 chaperone system can attempt to untangle aggregated proteins before handing them off to the proteasome.20PubMed Central. A Potential Mechanism for Targeting Aggregates With Proteasomes and Disaggregases in Liquid Droplets
Autophagy is particularly important for larger inclusions. A selective form called aggrephagy specifically targets protein aggregates for destruction. Interestingly, the molecular rules governing which aggregates get eaten are not as simple as previously thought. Experiments with engineered protein aggregates showed that the adapter protein p62, long assumed to be essential for recognizing aggregates and flagging them for autophagy, is actually dispensable in some contexts. Aggregates tagged with certain structural domains were efficiently cleared by autophagy even when p62 and a related adapter called NBR1 were both knocked out.21Nature Communications. Molecular determinants of selective clearance of protein inclusions by autophagy This suggests that cells have backup recognition systems for identifying dangerous aggregates, which is encouraging from a therapeutic standpoint.
Given the importance of these clearance pathways, researchers are actively pursuing drugs that boost autophagy as a way to remove toxic protein deposits in neurodegenerative disease. Multiple forms of autophagy, including macroautophagy, chaperone-mediated autophagy, and microautophagy, show promise as therapeutic avenues for eliminating the misfolded proteins implicated in conditions like Alzheimer’s and Parkinson’s.22PubMed. Activating autophagy to eliminate toxic protein aggregates with small molecules in neurodegenerative diseases The challenge, as noted in the toxicity discussion above, is ensuring that dissolved aggregates are fully degraded rather than merely dispersed into smaller, more toxic oligomeric species.
Detecting and Imaging Inclusion Bodies
One of the oldest and most widely used tools for identifying amyloid-type inclusion bodies is the fluorescent dye Thioflavin T, first described for this purpose in 1959. When Thioflavin T binds to the cross-beta-sheet structure characteristic of amyloid fibrils, its fluorescence emission increases dramatically, making even small deposits visible under a microscope.23PubMed Central. Molecular mechanism of Thioflavin-T binding to amyloid fibrils The binding mechanism is more complex than it appears: at the concentrations typically used in laboratory assays, the dye forms tiny micelles that then line up along the length of a fibril, and disrupting micelle formation at low pH sharply reduces the fluorescence signal.24PubMed. Mechanism of thioflavin T binding to amyloid fibrils Despite these quirks, Thioflavin T remains a workhorse in both diagnostic pathology and laboratory research on protein aggregation.
For researchers who need to see what an inclusion body actually looks like inside an intact cell, cryo-electron tomography has been transformative. By flash-freezing cells and capturing thousands of tilted images that can be reconstructed into a three-dimensional volume, this technique reveals inclusion architecture at molecular resolution without the distortions introduced by chemical fixation. Cryo-electron tomography of neuronal alpha-synuclein inclusions showed fibrils crisscrossing through and around trapped cellular organelles, directly visualizing the organelle entrapment that drives toxicity.25Nature Communications. In situ architecture of neuronal α-Synuclein inclusions Applied to a mouse model of neuronal intranuclear inclusion disease, the same technique revealed that polyglycine inclusions are built from interconnected ribbon-like assemblies rather than canonical amyloid fibrils, with different ribbon packing in the nucleus versus the cytoplasm and strikingly different accessibility to proteasomes depending on the compartment.26PubMed Central. Structural Polymorphism of polyG Inclusions Revealed by In Situ Cryo-Electron Tomography Findings like these underscore that not all inclusion bodies are structurally alike, even when they share a common aggregation theme.
Inclusion Bodies in Biotechnology
Outside of disease, cytoplasmic inclusion bodies have an entirely different reputation: they are a nuisance, and sometimes a useful one, in the production of recombinant proteins. When bacteria like E. coli are engineered to produce large quantities of a foreign protein, the protein frequently misfolds and piles up into dense, insoluble inclusion bodies. These aggregates are easy to isolate because they are so dense, but getting the protein back into its active, correctly folded shape is the expensive part of the process.
Traditional methods involved dissolving inclusion bodies in harsh chemicals like high concentrations of urea or guanidinium chloride, then slowly removing the denaturant and hoping the protein would refold. Recovery rates were often poor. More recent approaches exploit the finding that proteins inside bacterial inclusion bodies retain a surprising amount of native-like secondary structure rather than being completely scrambled. By using gentler solubilization conditions, such as alkaline pH with only modest urea concentrations, researchers have achieved recovery of over 40 percent of bioactive protein from inclusion bodies.27PubMed. Solubilization and refolding of bacterial inclusion body proteins The key insight is that preserving whatever native-like structure survives in the aggregate makes refolding much easier.28PubMed Central. Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process
Miniaturized refolding technologies are also emerging. Microfluidic chips that carefully control the rate at which denaturant is removed can produce refolded protein with higher helical content, comparable to conventional multi-day dialysis but completed in a fraction of the time.29PubMed Central. Refolding Techniques for Recovering Biologically Active Proteins from Inclusion Bodies And inclusion bodies are no longer just a bacterial phenomenon. Functional inclusion bodies have been produced in the yeast Pichia pastoris, similar in size and morphology to those from E. coli, and once purified, these yeast-derived aggregates can interact with and penetrate mammalian cell membranes without toxicity.30PubMed Central. Functional inclusion bodies produced in the yeast Pichia pastoris This opens the door to using engineered inclusion bodies as vehicles for delivering bioactive proteins directly to human cells.
Aging and the Asymmetric Inheritance of Aggregates
One of the more striking connections between inclusion bodies and biology has little to do with disease in the usual sense. In organisms that divide asymmetrically, such as budding yeast, protein aggregates are not split equally between mother and daughter cells. Instead, the mother cell retains the bulk of the aggregated material while the daughter cell is born relatively clean. Studies tracking fluorescent markers of protein aggregation found that aggregates accumulate in cells with older poles, and this buildup accounts for more than 30 percent of the loss of reproductive ability, or aging, in those cells. The daughter cell, devoid of parental inclusion bodies, effectively starts fresh, a form of cellular rejuvenation.31PubMed Central. Asymmetric segregation of protein aggregates is associated with cellular aging and rejuvenation Whether something analogous plays out in human tissues, where cells divide less frequently, remains an open question, but the yeast data make a striking case that managing inclusion bodies is not just about avoiding disease but about controlling aging itself at the single-cell level.